Our results suggest that Verrucarin J, a small molecule, effectively suppresses activation of EGFR/AKT/mTOR axis, resulting in growth inhibition and EMT phenotype of NSCLC cell lines. Here, MTOR is linked to non-small cell lung carcinoma.